Literature DB >> 26076747

IL2RG reversion event in a common lymphoid progenitor leads to delayed diagnosis and milder phenotype.

Amy P Hsu1, Stefania Pittaluga, Bianca Martinez, Amy P Rump, Mark Raffeld, Gulbu Uzel, Jennifer M Puck, Alexandra F Freeman, Steven M Holland.   

Abstract

Severe combined immunodeficiency (SCID) is most frequently caused by mutations in the cytokine receptor common gamma chain, CD132, encoded by the X-linked gene, IL2RG. Most patients present in the first year of life with failure to thrive, severe, opportunistic infections and absence of CD3+ T cells. We present a patient with pediatric illness and a diagnosis of combined variable immune deficiency (CVID) who was diagnosed at age 23 with an inherited IL2RG mutation causing loss of signal transduction through CD132. His peripheral blood included CD3/CD4 and CD3/CD8 positive cells as well as low levels of CD19+ B cells containing a reversion to the wildtype IL2RG allele. The reversion, which was not present at birth, may account for his mild phenotype and late diagnosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26076747      PMCID: PMC4504777          DOI: 10.1007/s10875-015-0174-0

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  18 in total

1.  Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles.

Authors:  Jennifer M Puck
Journal:  J Allergy Clin Immunol       Date:  2012-01-29       Impact factor: 10.793

2.  Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.

Authors:  V Stephan; V Wahn; F Le Deist; U Dirksen; B Broker; I Müller-Fleckenstein; G Horneff; H Schroten; A Fischer; G de Saint Basile
Journal:  N Engl J Med       Date:  1996-11-21       Impact factor: 91.245

3.  IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo.

Authors:  Mike Recher; Lucinda J Berglund; Danielle T Avery; Morton J Cowan; Andrew R Gennery; Joanne Smart; Jane Peake; Melanie Wong; Sung-Yun Pai; Sachin Baxi; Jolan E Walter; Umaimainthan Palendira; Gillian A Tangye; Michael Rice; Shannon Brothers; Waleed Al-Herz; Hans Oettgen; Hermann Eibel; Jennifer M Puck; Federica Cattaneo; John B Ziegler; Silvia Giliani; Stuart G Tangye; Luigi D Notarangelo
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

4.  Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo.

Authors:  Christian A J Vosshenrich; Thomas Ranson; Sandrine I Samson; Erwan Corcuff; Francesco Colucci; Eleftheria E Rosmaraki; James P Di Santo
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

5.  Multiple reversions of an IL2RG mutation restore T cell function in an X-linked severe combined immunodeficiency patient.

Authors:  Tomoki Kawai; Megumu Saito; Ryuta Nishikomori; Takahiro Yasumi; Kazushi Izawa; Tomohiko Murakami; Shigefumi Okamoto; Yasuko Mori; Noriko Nakagawa; Kohsuke Imai; Shigeaki Nonoyama; Taizo Wada; Akihiro Yachie; Katsuyuki Ohmori; Tatsutoshi Nakahata; Toshio Heike
Journal:  J Clin Immunol       Date:  2012-03-30       Impact factor: 8.317

Review 6.  IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2.

Authors:  J G Giri; D M Anderson; S Kumaki; L S Park; K H Grabstein; D Cosman
Journal:  J Leukoc Biol       Date:  1995-05       Impact factor: 4.962

7.  The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.

Authors:  J M Puck; S M Deschênes; J C Porter; A S Dutra; C J Brown; H F Willard; P S Henthorn
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

8.  Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor complex.

Authors:  Y Kimura; T Takeshita; M Kondo; N Ishii; M Nakamura; J Van Snick; K Sugamura
Journal:  Int Immunol       Date:  1995-01       Impact factor: 4.823

9.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor.

Authors:  S M Russell; A D Keegan; N Harada; Y Nakamura; M Noguchi; P Leland; M C Friedmann; A Miyajima; R K Puri; W E Paul
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

10.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor.

Authors:  M Noguchi; Y Nakamura; S M Russell; S F Ziegler; M Tsang; X Cao; W J Leonard
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

View more
  13 in total

Review 1.  Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Authors:  Patrick A Flume; James D Chalmers; Kenneth N Olivier
Journal:  Lancet       Date:  2018-09-08       Impact factor: 79.321

2.  A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency.

Authors:  Motoi Yamashita; Ryosuke Wakatsuki; Tamaki Kato; Tsubasa Okano; Shingo Yamanishi; Nobuko Mayumi; Mayuri Tanaka; Yumi Ogura; Hirokazu Kanegane; Shigeaki Nonoyama; Kohsuke Imai; Tomohiro Morio
Journal:  Int J Hematol       Date:  2019-03-08       Impact factor: 2.490

3.  Progressive B Cell Loss in Revertant X-SCID.

Authors:  Connie H Lin; Hye Sun Kuehn; Timothy J Thauland; Christine M Lee; Suk See De Ravin; Harry L Malech; Timothy J Keyes; Astraea Jager; Kara L Davis; Maria I Garcia-Lloret; Sergio D Rosenzweig; Manish J Butte
Journal:  J Clin Immunol       Date:  2020-07-17       Impact factor: 8.317

4.  The effect of mutatio-type on proteo-phenotype and clinico-phenotype in selected primary immunodeficiencies.

Authors:  Sevil Oskay Halacli
Journal:  Immunol Res       Date:  2021-10-07       Impact factor: 2.829

5.  Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer Cells.

Authors:  Andrea Lisco; Amy P Hsu; Dimana Dimitrova; Diana M Proctor; Emily M Mace; Peiying Ye; Megan V Anderson; Stephanie N Hicks; Christopher Grivas; Dima A Hammoud; Maura Manion; Gabriel J Starrett; Alvin Farrel; Kerry Dobbs; Isaac Brownell; Christopher Buck; Luigi D Notarangelo; Jordan S Orange; Warren J Leonard; Michael I Orestes; Anju T Peters; Jennifer A Kanakry; Julia A Segre; Heidi H Kong; Irini Sereti
Journal:  N Engl J Med       Date:  2021-09-02       Impact factor: 176.079

6.  Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism.

Authors:  Yusuke Okuno; Akihiro Hoshino; Hideki Muramatsu; Nozomu Kawashima; Xinan Wang; Kenichi Yoshida; Taizo Wada; Masaharu Gunji; Tomoko Toma; Tamaki Kato; Yuichi Shiraishi; Atsuko Iwata; Toshinori Hori; Toshiyuki Kitoh; Kenichi Chiba; Hiroko Tanaka; Masashi Sanada; Yoshiyuki Takahashi; Shigeaki Nonoyama; Masafumi Ito; Satoru Miyano; Seishi Ogawa; Seiji Kojima; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2015-09-26       Impact factor: 8.317

7.  The IL-2RG R328X nonsense mutation allows partial STAT-5 phosphorylation and defines a critical region involved in the leaky-SCID phenotype.

Authors:  A Arcas-García; M Garcia-Prat; M Magallón-Lorenz; A Martín-Nalda; O Drechsel; S Ossowski; L Alonso; J G Rivière; P Soler-Palacín; R Colobran; J Sayós; M Martínez-Gallo; C Franco-Jarava
Journal:  Clin Exp Immunol       Date:  2020-01-19       Impact factor: 4.330

Review 8.  Somatic genetic rescue in Mendelian haematopoietic diseases.

Authors:  Patrick Revy; Caroline Kannengiesser; Alain Fischer
Journal:  Nat Rev Genet       Date:  2019-06-11       Impact factor: 53.242

9.  Novel Hemizygous IL2RG p.(Pro58Ser) Mutation Impairs IL-2 Receptor Complex Expression on Lymphocytes Causing X-Linked Combined Immunodeficiency.

Authors:  Elina A Tuovinen; Juha Grönholm; Tiina Öhman; Sakari Pöysti; Raine Toivonen; Anna Kreutzman; Kaarina Heiskanen; Luca Trotta; Sanna Toiviainen-Salo; John M Routes; James Verbsky; Satu Mustjoki; Janna Saarela; Juha Kere; Markku Varjosalo; Arno Hänninen; Mikko R J Seppänen
Journal:  J Clin Immunol       Date:  2020-02-19       Impact factor: 8.317

Review 10.  Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease.

Authors:  Elena Blanco; Natalia Izotova; Claire Booth; Adrian James Thrasher
Journal:  Front Immunol       Date:  2020-11-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.